文献速递角膜与眼表疾病

整合素α9阻断抑制淋巴管瓣膜形成并促进移植存活

Integrin Alpha 9 Blockade Suppresses Lymphatic Valve Formation and Promotes Transplant Survival.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2016-01-01

研究在全错配C57BL/6供体与BALB/c受体小鼠间行原位角膜移植,受体随机接受结膜下注射Itga-9阻断抗体或同型对照,每周两次共8周。结果显示抗Itga-9治疗抑制移植后淋巴管瓣膜形成,不影响淋巴管形成及其鼻侧极化分布,并显著促进移植物存活。

要点

  • 抗Itga-9治疗抑制角膜移植后淋巴管瓣膜形成。
  • 抗Itga-9治疗不影响淋巴管形成及鼻侧极化分布。
  • Itga-9阻断显著促进移植物存活。

核心结论

  • 淋巴管瓣膜形成与移植排斥密切相关,靶向Itga-9可能成为干扰免疫反应、促进移植物存活的新策略。

研究设计与样本

  • 研究采用全错配C57BL/6(供体)与BALB/c(受体)小鼠行原位角膜移植。
  • 受体随机接受结膜下注射Itga-9阻断抗体或同型对照,每周两次共8周。
  • 移植片在体经眼科裂隙灯活体显微检查并用Kaplan-Meier生存曲线分析,离体行全角膜铺片免疫荧光显微镜评估淋巴管和瓣膜。

主要发现

  • 抗Itga-9治疗抑制移植后淋巴管瓣膜形成。
  • 该治疗不影响淋巴管形成及其在角膜的鼻侧极化分布。
  • Itga-9阻断显著促进移植物存活。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The lymphatic pathway mediates transplant rejection. We recently reported that lymphatic vessels develop luminal valves in the cornea during lymphangiogenesis, and these valves express integrin alpha 9 (Itga-9) and play a critical role in directing lymph flow. In this study, we used an allogeneic corneal transplantation model to investigate whether Itga-9 blockade could suppress valvulogenesis after transplantation, and how this effect would influence the outcomes of the transplants. METHODS: Orthotopic corneal transplantation was performed between fully mismatched C57BL/6 (donor) and BALB/c (recipient) mice. The recipients were randomized to receive subconjunctival injections of either Itga-9 blocking antibody or isotype control twice a week for 8 weeks. Corneal grafts were assessed in vivo by ophthalmic slit-lamp biomicroscopy and analyzed using Kaplan-Meier survival curves. Additionally, whole-mount full-thickness corneas were evaluated ex vivo by immunofluorescent microscopy on both lymphatic vessels and valves. RESULTS: Anti-Itga-9 treatment suppressed lymphatic valvulogenesis after transplantation. Our treatment did not affect lymphatic vessel formation or their nasal polarized distribution in the cornea. More importantly, Itga-9 blockade led to a significant promotion of graft survival. CONCLUSIONS: Lymphatic valvulogenesis is critically involved in transplant rejection. Itga-9 targeting may offer a new and effective strategy to interfere with the immune responses and promote graft survival.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Kang GJ, Truong T, Huang E, et al. Integrin Alpha 9 Blockade Suppresses Lymphatic Valve Formation and Promotes Transplant Survival. Invest Ophthalmol Vis Sci. 2016. PMID: 27806381. doi:10.1167/iovs.16-20130

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。